ASX - Day Trading
|
|
Re:
Afternoon trading March 18
|
|
Area51
|
228 |
100K |
2 |
18/03/19 |
18/03/19 |
ASX - Day Trading
|
228
|
100K
|
2
|
|
ASX - By Stock
|
FAU |
Re:
Ann: SIGNIFICANT LODE GOLD INTERSECTED DURING GIMLET DRILLING
|
|
Area51
|
16 |
21K |
4 |
18/03/19 |
18/03/19 |
ASX - By Stock
|
16
|
21K
|
4
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Adidi-Kanga Gold Project Acquisition and Update
|
|
Area51
|
271 |
110K |
10 |
13/03/19 |
13/03/19 |
ASX - By Stock
|
271
|
110K
|
10
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Adidi-Kanga Gold Project Acquisition and Update
|
|
Area51
|
271 |
110K |
6 |
13/03/19 |
13/03/19 |
ASX - By Stock
|
271
|
110K
|
6
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Appendix 3B
|
|
Area51
|
32 |
9.9K |
0 |
11/03/19 |
11/03/19 |
ASX - By Stock
|
32
|
9.9K
|
0
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Appendix 3B
|
|
Area51
|
32 |
9.9K |
3 |
11/03/19 |
11/03/19 |
ASX - By Stock
|
32
|
9.9K
|
3
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Appendix 3B
|
|
Area51
|
32 |
9.9K |
2 |
11/03/19 |
11/03/19 |
ASX - By Stock
|
32
|
9.9K
|
2
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Appendix 3B
|
|
Area51
|
32 |
9.9K |
1 |
11/03/19 |
11/03/19 |
ASX - By Stock
|
32
|
9.9K
|
1
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Appendix 3B
|
|
Area51
|
32 |
9.9K |
1 |
11/03/19 |
11/03/19 |
ASX - By Stock
|
32
|
9.9K
|
1
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Extension of Voluntary Suspension
|
|
Area51
|
68 |
20K |
26 |
06/03/19 |
06/03/19 |
ASX - By Stock
|
68
|
20K
|
26
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Voluntary Suspension
|
|
Area51
|
275 |
96K |
22 |
09/02/19 |
09/02/19 |
ASX - By Stock
|
275
|
96K
|
22
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Reinstatement to Official Quotation
|
|
Area51
|
382 |
131K |
9 |
22/01/19 |
22/01/19 |
ASX - By Stock
|
382
|
131K
|
9
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Reinstatement to Official Quotation
|
|
Area51
|
382 |
131K |
8 |
18/01/19 |
18/01/19 |
ASX - By Stock
|
382
|
131K
|
8
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Reinstatement to Official Quotation
|
|
Area51
|
382 |
131K |
2 |
17/01/19 |
17/01/19 |
ASX - By Stock
|
382
|
131K
|
2
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Reinstatement to Official Quotation
|
|
Area51
|
382 |
131K |
7 |
17/01/19 |
17/01/19 |
ASX - By Stock
|
382
|
131K
|
7
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Reinstatement to Official Quotation
|
|
Area51
|
382 |
131K |
1 |
17/01/19 |
17/01/19 |
ASX - By Stock
|
382
|
131K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Chart
|
|
Area51
|
23 |
10K |
0 |
13/12/18 |
13/12/18 |
ASX - By Stock
|
23
|
10K
|
0
|
|
ASX - By Stock
|
VEC |
Re:
VEC chart
|
|
Area51
|
473 |
163K |
0 |
15/11/18 |
15/11/18 |
ASX - By Stock
|
473
|
163K
|
0
|
|
ASX - By Stock
|
VEC |
Re:
VEC chart
|
|
Area51
|
473 |
163K |
3 |
15/11/18 |
15/11/18 |
ASX - By Stock
|
473
|
163K
|
3
|
|
ASX - By Stock
|
VEC |
Re:
General comments
|
|
Area51
|
1.4K |
500K |
3 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
1.4K
|
500K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study
|
|
Area51
|
369 |
181K |
0 |
30/10/18 |
30/10/18 |
ASX - By Stock
|
369
|
181K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study
|
|
Area51
|
369 |
181K |
3 |
30/10/18 |
30/10/18 |
ASX - By Stock
|
369
|
181K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study
|
|
Area51
|
369 |
181K |
4 |
30/10/18 |
30/10/18 |
ASX - By Stock
|
369
|
181K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study
|
|
Area51
|
369 |
181K |
8 |
30/10/18 |
30/10/18 |
ASX - By Stock
|
369
|
181K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study
|
|
Area51
|
369 |
181K |
1 |
30/10/18 |
30/10/18 |
ASX - By Stock
|
369
|
181K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study
|
|
Area51
|
369 |
181K |
1 |
30/10/18 |
30/10/18 |
ASX - By Stock
|
369
|
181K
|
1
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Pause in Trading
|
|
Area51
|
280 |
88K |
1 |
25/10/18 |
25/10/18 |
ASX - By Stock
|
280
|
88K
|
1
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Pause in Trading
|
|
Area51
|
280 |
88K |
6 |
25/10/18 |
25/10/18 |
ASX - By Stock
|
280
|
88K
|
6
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Pause in Trading
|
|
Area51
|
280 |
88K |
15 |
25/10/18 |
25/10/18 |
ASX - By Stock
|
280
|
88K
|
15
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Pause in Trading
|
|
Area51
|
280 |
88K |
21 |
24/10/18 |
24/10/18 |
ASX - By Stock
|
280
|
88K
|
21
|
|
ASX - By Stock
|
VEC |
Re:
Ann: Pause in Trading
|
|
Area51
|
280 |
88K |
9 |
24/10/18 |
24/10/18 |
ASX - By Stock
|
280
|
88K
|
9
|
|
ASX - By Stock
|
IHL |
Re:
Ann: Medicinal Cannabis Product Licensing Applications
|
|
Area51
|
62 |
15K |
0 |
24/10/18 |
24/10/18 |
ASX - By Stock
|
62
|
15K
|
0
|
|
ASX - By Stock
|
CRR |
Re:
4CE Chart
|
|
Area51
|
1.4K |
615K |
7 |
11/09/18 |
11/09/18 |
ASX - By Stock
|
1.4K
|
615K
|
7
|
|
ASX - By Stock
|
CRR |
Re:
4CE Chart
|
|
Area51
|
1.4K |
615K |
1 |
04/09/18 |
04/09/18 |
ASX - By Stock
|
1.4K
|
615K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
1 |
04/09/18 |
04/09/18 |
ASX - By Stock
|
369
|
195K
|
1
|
|
ASX - By Stock
|
CRR |
Re:
4CE Chart
|
|
Area51
|
1.4K |
615K |
1 |
04/09/18 |
04/09/18 |
ASX - By Stock
|
1.4K
|
615K
|
1
|
|
ASX - By Stock
|
CRR |
Re:
4CE Chart
|
|
Area51
|
1.4K |
615K |
1 |
04/09/18 |
04/09/18 |
ASX - By Stock
|
1.4K
|
615K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
1 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
369
|
195K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
0 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
369
|
195K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
0 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
369
|
195K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
1 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
369
|
195K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
0 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
369
|
195K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
6 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
369
|
195K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
1 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
369
|
195K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
1 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
369
|
195K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
0 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
369
|
195K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
2 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
369
|
195K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
1 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
369
|
195K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
3 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
369
|
195K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Positive Results for Australian Prospective Paediatric Study
|
|
Area51
|
369 |
195K |
3 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
369
|
195K
|
3
|
|